Rational Second-Generation Antiandrogen Use in Prostate Cancer

The second-generation antiandrogens have achieved an ever-growing list of approvals and indications in subsets of prostate cancer. Here, we provide an overview of second-generation antiandrogen trials and FDA approvals and outline a rational sequencing approach for the use of these agents as they re...

Descripción completa

Detalles Bibliográficos
Autores principales: Orme, Jacob J, Pagliaro, Lance C, Quevedo, J Fernando, Park, Sean S, Costello, Brian A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Genitourinary Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895732/
https://www.ncbi.nlm.nih.gov/pubmed/35641216
http://dx.doi.org/10.1093/oncolo/oyab045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895732/
https://www.ncbi.nlm.nih.gov/pubmed/35641216
http://dx.doi.org/10.1093/oncolo/oyab045

Ejemplares similares